Expert Analysis

Resistance, New Agents, and Management of Antiretroviral-Experienced Patients

Source: CCO Independent Conference Coverage of the 2004 International AIDS Conference*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Resistance, New Agents, and Management of Antiretroviral-Experienced Patients


Program Director: John P. Phair, MD

Faculty:

Daniel R. Kuritzkes, MDWilliam A. O'Brien, MD, MSAndrew R. Zolopa, MD
  • Daniel R. Kuritzkes, MD
  • William A. O'Brien, MD, MS
  • Andrew R. Zolopa, MD

CME CREDIT INFORMATION

Release Date: 08/19/04

Expiration Date: 08/18/05


Physicians: maximum of 2.0 AMA PRA Category 1 Credits™

Registered Nurses: 2.6 Nursing CE credits

Pharmacists: 2.25 contact hours (0.23 CEUs)

Status: Please log in to view status

Begin the Expert Analysis

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the results of recent clinical studies of antiretrovirals regimens for treatment-experienced patients

  • Describe novel antiretroviral agents currently in clinical studies

  • Review new findings regarding resistance to NRTIs


Earn CME credit by reading the expert analysis and commentary on resistance. Topics covered include:

  • Fosamprenavir/Ritonavir in PI-Experienced Patients
  • Resistance to Lopinavir/Ritonavir
  • Efficacy of Boosted Tipranavir
  • Management of Resistance to NRTIs
  • Genotypic Predictors of Response to Didanosine
  • Lamivudine Monotherapy vs Treatment Interruption
  • Longer-term Follow-up of Response to Enfuvirtide
  • Chemokine Receptor Antagonists
  • Resistance Issues in Prevention of Mother-to-Child Transmission
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Pharmacist and nursing credit provided through the cosponsorship of Medical Education Collaborative and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.

CCO Resources

CCO Expert Recap of data from the 2004 International AIDS Conference

CCO Expert Recap
CCO Slideset